Greg D. Carmichael - 15 Jul 2026 Form 4 Insider Report for Encompass Health Corp (EHC)

Reporting relationship: Director
Issuer ticker: EHC
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jul 2026, 16:09:01 UTC
Prior SEC filing: 11 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Patrick Darby, attorney-in-fact for Greg D. Carmichael

Key filing fact

Greg D. Carmichael filed Form 4 for Encompass Health Corp (EHC) on 16 Jul 2026.

Key facts

This page summarizes Greg D. Carmichael's Form 4 filing for Encompass Health Corp (EHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jul 2026, 16:09.

Change

Previous filing in this sequence was filed on 11 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001247734 Primary reporting owner

CARMICHAEL GREG D

Relationship: Director
Address: 9001 LIBERTY PARKWAY, BIRMINGHAM
Signature: /s/ Patrick Darby, attorney-in-fact for Greg D. Carmichael
Signature date: 16 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Award

Transaction value
Shares: +29
Change %: +0.14%
Price: $0.000000^*
Shares after: 20,349
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.